Multiplex qPCR vs. Singleplex qPCR: Key Differences, Benefits, and Experimental Considerations
Exhibitor: MEDCLUB SCIENTIFIC CO., LTD.
Date: 2026-05-12
Booth No.: L1025
Real-time quantitative PCR (qPCR) has significantly improved the efficiency of nucleic acid detection and quantitative analysis. It offers high sensitivity, rapid detection, and strong application flexibility. Many real-time PCR experiments detect only one target in each reaction well; this approach is known as singleplex qPCR.
Multiplex qPCR further enhances the efficiency of real-time PCR analysis. In a multiplex qPCR reaction, multiple independent target sequences can be amplified and detected simultaneously within the same reaction well. This allows researchers to obtain more analytical data with fewer reactions, while improving reagent efficiency and experimental consistency.
Whether used for gene expression analysis or pathogen detection, multiplex qPCR can effectively simplify experimental workflows.
From Singleplex to Multiplex: How It Works
A typical real-time PCR reaction usually contains a pair of primers. When using the TaqMan™ probe-based method, a fluorescently labeled probe is also included in the reaction. In a singleplex qPCR experiment, each reaction well typically amplifies and detects only one target sequence.
In multiplex qPCR, two or more targets can be amplified simultaneously in the same reaction well. Each target is distinguished by a probe labeled with a different fluorescent dye.
Among existing qPCR reaction systems, the TaqMan™ probe-based method is particularly suitable for multiplex qPCR. Because the probe itself provides high specificity, and each probe can be paired with a different fluorescent dye, individual target sequences can be distinguished by different fluorescent signals.
This dual advantage enables researchers to amplify multiple assays in a single reaction while accurately detecting each target independently.
Why Choose Multiplex qPCR?
Compared with singleplex qPCR, multiplex qPCR offers several significant advantages:
Higher throughput: More targets can be detected in each well, improving the overall efficiency of the entire reaction plate.
Lower reagent and sample consumption: Multiplex qPCR allows more efficient use of costly reagents and limited biological samples.
Greater precision and reliability: Multiplex qPCR allows the target sequence and internal control to be analyzed in the same reaction well. This helps reduce well-to-well variation and improves data comparability and reliability.
In many cases, starting with duplex qPCR is a practical first step. As the technology continues to advance, the advantages of multiplex qPCR become even more significant when three or more targets are combined in a single reaction.
With advanced tools, services, and product support from Thermo Fisher Scientific, higher-order multiplex qPCR, with up to six targets, is now increasingly achievable.
When Is Multiplex qPCR Most Useful?
Multiplex qPCR is especially valuable in the following situations:
When the same set of assays needs to be applied to a large number of samples.
When high data quality and strict quality control are required.
When sample volume is limited or the sample is especially precious.
When a study requires the detection of many targets, for example more than 12 targets, a real-time PCR array may be considered to improve overall analysis efficiency.
As the number of targets in a multiplex reaction increases, especially from three to six targets, the complexity of experimental design also increases significantly. In such cases, technical application scientists (TAS) and field application scientists (FAS) can provide professional guidance.
How to Design a Successful Multiplex qPCR Experiment
A successful multiplex qPCR workflow requires careful experimental design and thorough testing. Key considerations include the following:
Selecting Compatible Assays
The first step is to determine which assays you would like to combine. The achievable level of multiplexing depends on the number of optical detection channels available on the qPCR instrument. For example, if the instrument has six detection channels, it can theoretically detect up to six targets simultaneously.
The Multiplexing Support Request Tool in the qPCR Assay Design Hub can be used to evaluate assay compatibility. A multiplex analysis support team can also provide in silico analysis to help assess whether primers or probes may interfere with one another.
Selecting Appropriate Fluorescent Dyes
Proper dye selection helps achieve clear spectral separation between targets.
Recommended dyes include FAM, VIC, ROX, Cy5, Cy5.5, and Cy3. Most Applied Biosystems™ reagents contain the passive reference dye ROX™, which is especially beneficial in multiplex qPCR.
The Q9600 Series supports multiplex qPCR experiments without requiring a ROX channel. Users may select the appropriate fluorescent dyes according to their experimental needs, without additional dye calibration.
Optimizing Primer Concentration
In singleplex TaqMan assays, a uniform primer concentration of 900 nM is typically recommended.
However, in multiplex reactions, using the same concentration for all primer pairs may cause high-abundance targets to amplify rapidly. This may lead to depletion or saturation of Taq DNA polymerase, thereby suppressing the amplification of low-abundance targets.
To avoid this situation, primer-limiting strategies may be applied to selected assays.
Researchers should determine which assays require primer limitation based on the expected abundance of each target.
Under standard conditions, high-abundance targets may quickly reach polymerase saturation and enter the linear amplification phase. Low-abundance targets may then also be forced into the linear phase, resulting in inaccurate Ct values or even failed detection.
By limiting primer concentration, amplification enters the linear phase due to primer depletion rather than polymerase saturation. This helps ensure that low-abundance targets remain in the exponential amplification phase.
VIC-labeled, primer-limited (PL) gene expression assays are available. Custom TaqMan™ Gene Expression Assays and specialty oligonucleotide synthesis services can also provide different dye and PL format options.
Performance Testing Before Scale-Up
Before multiplex qPCR is formally applied, its performance must be verified.
A more stringent approach is to use mixed standard curves. In this method, one target is serially diluted while a fixed amount of a second target is added. The mixed samples are then amplified by real-time PCR. Ideally, both targets should maintain good linearity across the full detection range.
For triplex or higher-order multiplex reactions, multiple target combinations should be tested.
A simplified approach is to run singleplex and multiplex amplification on the same set of samples, and then compare the consistency of the results.
Integrating Multiplex Assays into a Single-Tube Reagent Format
If the performance verification results of the multiplex qPCR assay are satisfactory, all assays can be premixed into a single-tube format using specialty oligonucleotides.
This approach offers several advantages:
It simplifies reaction setup.
It helps ensure consistent primer and probe ratios.
It improves experimental reproducibility.
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
